Mid-Morning Market Update: Markets Rise; Jobless Claims Fall To 310,000

Following the market opening Thursday, the Dow traded up 0.36% to 35,158.32 while the NASDAQ rose 0.41% to 15,348.81. The S&P also rose, gaining 0.26% to 4,525.59.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 40,456,810 cases with around 652,670 deaths. India confirmed a total of at least 33,139,980 cases and 441,740 deaths, while Brazil reported over 20,928,000 COVID-19 cases with 584,420 deaths. In total, there were at least 222,596,490 cases of COVID-19 worldwide with more than 4,596,860 deaths, according to data compiled by Johns Hopkins University.


Leading and Lagging Sectors


Energy shares gained 1.5% on Thursday. Meanwhile, top gainers in the sector included Gevo, Inc. GEVO, up 30% and Frontline Ltd. FRO up 5%.


In trading on Thursday, real estate shares fell by 0.9%.


Top Headline

US initial jobless claims dropped to 310 thousand in the week ending September 4, versus previous week's level revised level of 345,000. However, analysts were expecting a reading of 335 thousand.

 

Equities Trading UP


Gevo, Inc. GEVO shares shot up 30% to $7.50. Chevron and Gevo announced intent to pursue sustainable aviation fuel investment.


Shares of Offerpad Solutions Inc OPAD got a boost, shooting 38% to $15.91.


Torrid Holdings Inc. CURV shares were also up, gaining 26% to $23.27 after the company reported better-than-expected Q2 EPS and sales results. Torrid sees Q3 sales of $305 million - $315 million, above the consensus of $294.74 million. The company expects FY21 sales of $1.29 billion - $1.31 billion, above the consensus of $1.26 billion.

Check out these big movers of the day


Equities Trading DOWN

Humanigen, Inc. HGEN shares tumbled 54% to $6.89 after the company said the Food and Drug Administration has declined its request for emergency use authorization of lenzilumab to treat newly hospitalized COVID-19 patients. JP Morgan downgraded Humanigen from Neutral to Underweight.

Shares of Tuesday Morning Corporation TUEM were down 35% to $2.7576 after the company reported downbeat Q4 earnings.

Invacare Corporation IVC was down, falling 34% to $5.48 after updating Q3 FY21 guidance. The Company said that headwinds related to labor, material, and freight, will continue to impact its business. For Q3 FY21, Invacare expects constant currency net sales of 0% - 4% Y/Y, against the growth rate of 4% - 7% expected earlier.


Commodities


In commodity news, oil traded up 0.6% to $69.71, while gold traded down 0.2% to $1,789.40.


Silver traded up 0.1% Thursday to $24.065 while copper rose 1.2% to $4.2850.


Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.3%, the Spanish Ibex Index fell 0.2% and the German DAX 30 gained 0.5%. Meanwhile, the London’s FTSE 100 fell 0.8%, French CAC 40 rose 0.6% and Italy’s FTSE MIB rose 0.4%.

The trade surplus for Germany narrowed to €18.1 billion in July from €19.2 billion in the year-ago period, while current account surplus shrank to EUR 17.6 billion from EUR 20.2 billion.


Economics

US initial jobless claims dropped to 310 thousand in the week ending September 4, versus previous week's level revised level of 345,000. However, analysts were expecting a reading of 335 thousand.


Dallas Fed President Robert Kaplan is set to speak at 12:00 p.m. ET.


Federal Reserve Governor Michelle Bowman will speak at 1:00 p.m. ET.


The Treasury will auction 30-year bonds at 1:00 p.m. ET.


Federal Reserve Bank of New York President John Williams is set to speak at 2:00 p.m. ET.


Federal Reserve Bank of Boston President Eric Rosengren will speak at 4:25 p.m. ET.

Check out the full economic calendar here

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Morning Market Update
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...